Commentary: Emerging role of super vised injecting facilities in human immunodieficiency virus prevention

Addiction

Volumn 104, Issue 4, 2009, Pages 620-621

  Milloy, M J ^a,b   Wood, Evan ^a,b  

^a BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

HIV; Injection drug use; Supervised injection facilities; Syringe sharing

Indexed keywords

HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NOTE; ORGANIZATION AND MANAGEMENT; PREVENTIVE HEALTH SERVICE; RISK FACTOR; SUBSTANCE ABUSE;

HIV INFECTIONS; HIV-1; HUMANS; NEEDLE-EXCHANGE PROGRAMS; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 62649166384     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2009.02541.x     Document Type: Article

References (14)

1. Karon J. M., Fleming P. L., Steketee R. W., De Cock, K. M. HIV in the United States at the turn of the century: an epidemic in transition. Am J Public Health 2001 91 : 060 8.
2. United Nations Programme on HIV/AIDS (UNAIDS). 2006 report on the global AIDS epidemic. Available at: http://www.unaids.org/en/KnowledgeCentre/HIVData/ GlobalReport/2006/default.asp (accessed 11 February 2009).
3. Beletsky L., Davis C. S., Anderson E., Burris, S. The law (and politics) of safe injection facilities in the United States. Am J Public Health 2008 98 : 231 7.
4. Des Jarlais D. C., Arasteh K., Hagan, H. Evaluating Vancouver's supervised injection facility: data and dollars, symbols and ethics. Can Med Assoc J 2008 179 : 105 6.
5. Kerr T., Montaner J., Wood, E. Supervised injecting facilities: time for scale-up? Lancet 2008 372 : 354 5.
6. Guerma T., De Cock K. Priority Interventions: HIV/AIDS Prevention, Treatment and Care in the Health Sector. Geneva, Switzerland : HIV/AIDS Department, World Health Organization 2008.
7. Picard A. Clement's Insite attack leaves WHO red-faced. The Globe and Mail, 6 August 2008.
8. World Health Organization. Frequent Asked Questions (FAQ): XVII International AIDS Conference. Geneva, Switzerland : World Health Organization 2008.
9. Bravo M. J., Royuela L., De la Fuente L., Brugal M. T., Barrio G., Domingo-Salvany, A. et al. Use of supervised injection facilities and injection risk behaviours among young drug injectors. Addiction 2009 104 : 614 19.
10. Hedrich D. European Report on Drug Consumption Rooms. Lisbon, Portugal : European Monitoring Centre for Drugs and Drug Addiction 2004.
11. Kerr T., Tyndall M., Li K., Montaner J., Wood, E. Safer injection facility use and syringe sharing in injection drug users. Lancet 2005 366 : 316 118.
12. Wood E., Tyndall M., Stoltz J. A., Small W., Lloyd-Smith E., Zhang, R. et al. Factors associated with syringe sharing among users of a medically supervised safer injecting facility. Am J Infect Dis 2005 1 : 50 4.
13. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986 7 : 177 88.
14. Marshall B. D., Wood E., Zhang R., Tyndall M. W., Montaner J. S., Kerr, T. Condom use among injection drug users accessing a supervised injecting facility. Sex Transm Infect 2009 in press. DOI:10.1136/sti.2008.032524.